{"id":7394,"date":"2020-06-08T15:39:05","date_gmt":"2020-06-08T22:39:05","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=7394"},"modified":"2021-03-24T15:39:46","modified_gmt":"2021-03-24T22:39:46","slug":"seroprevalence-of-immunoglobulin-m-and-g-antibodies-against-sars-cov-2-in-china","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/06\/08\/seroprevalence-of-immunoglobulin-m-and-g-antibodies-against-sars-cov-2-in-china\/","title":{"rendered":"Seroprevalence of Immunoglobulin M and G Antibodies against SARS-CoV-2 in China"},"content":{"rendered":"<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"39\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Seroprevalence of\u00a0<\/span><span data-contrast=\"auto\">antibodies against SARS-CoV-2<\/span><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">was 4% among healthcare workers and 3% among their families<\/span><span data-contrast=\"auto\">\u00a0in the city of Wuhan<\/span><span data-contrast=\"auto\">, China<\/span><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">between March 9 and April 10<\/span><span data-contrast=\"auto\">.<\/span><span data-contrast=\"auto\">\u00a0In<\/span><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">other\u00a0<\/span><span data-contrast=\"auto\">cities in Hubei province,\u00a0<\/span><span data-contrast=\"auto\">seropositivity<\/span><span data-contrast=\"auto\">\u00a0was\u00a0<\/span><span data-contrast=\"auto\">lower\u00a0<\/span><span data-contrast=\"auto\">in cities that were further<\/span><span data-contrast=\"auto\">\u00a0from Wuhan. While\u00a0<\/span><span data-contrast=\"auto\">seropositivity<\/span><span data-contrast=\"auto\">\u00a0was\u00a0<\/span><span data-contrast=\"auto\">highest for IgG, some individuals were positive\u00a0<\/span><span data-contrast=\"auto\">only for<\/span><span data-contrast=\"auto\">\u00a0IgM, underscoring that\u00a0<\/span><span data-contrast=\"auto\">testing for both antibody types may be necessary in\u00a0<\/span><span data-contrast=\"auto\">seroprevalence studies.\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><i><span data-contrast=\"none\">Xu et al. (June 5, 2020). Seroprevalence of Immunoglobulin M and G Antibodies against SARS-CoV-2 in China. Nature Medicine.\u00a0<\/span><\/i><a href=\"https:\/\/doi.org\/10.1038\/s41591-020-0949-6\"><span data-contrast=\"none\">https:\/\/doi.org\/10.1038\/s41591-020-0949-6<\/span><\/a><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559685&quot;:1080,&quot;335559739&quot;:160,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Seroprevalence of\u00a0antibodies against SARS-CoV-2\u00a0was 4% among healthcare workers and 3% among their families\u00a0in the city of Wuhan, China\u00a0between March 9 and April 10.\u00a0In\u00a0other\u00a0cities in Hubei province,\u00a0seropositivity\u00a0was\u00a0lower\u00a0in cities that were further\u00a0from Wuhan. While\u00a0seropositivity\u00a0was\u00a0highest for IgG, some individuals were positive\u00a0only for\u00a0IgM, underscoring that\u00a0testing for both antibody types may be necessary in\u00a0seroprevalence studies.\u00a0\u00a0 Xu et al. (June 5,&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/06\/08\/seroprevalence-of-immunoglobulin-m-and-g-antibodies-against-sars-cov-2-in-china\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"topic":[21],"class_list":["post-7394","post","type-post","status-publish","format-standard","hentry","category-article-summary","topic-transmission"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/7394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=7394"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/7394\/revisions"}],"predecessor-version":[{"id":7395,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/7394\/revisions\/7395"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=7394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=7394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=7394"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=7394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}